Carbohydrate metabolism in Down's syndrome. 1979

K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura

Carbohydrate metabolism was studied in eight patients with Down's syndrome, aged 8 to 18 years. Diabetic glucose tolerance was observed in only one patient with obesity. This impaired glucose tolerance was improved with the weight reduction due to diet restriction. The flat glucose tolerance curves with low peak values were also observed in the other two patients. In the remaining five patients, normal glucose tolerance was obtained. Insulin response and free fatty acid levels during oral glucose load were not characteristic except for the diabetic patient with obesity. The sera of Down's syndrome showed normal binding capacity for insulin. These results suggest that obesity might partly participate in the impaired glucose tolerance in Down's syndrome.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
July 1974, Acta endocrinologica,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
July 1969, American journal of mental deficiency,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
October 1973, The Gazette of the Egyptian Paediatric Association,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
June 1982, Journal of mental deficiency research,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
August 1983, Science (New York, N.Y.),
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
October 1978, Voprosy okhrany materinstva i detstva,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
January 1982, Annals of the New York Academy of Sciences,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
August 1980, Wiadomosci lekarskie (Warsaw, Poland : 1960),
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
June 1966, The Journal of endocrinology,
K Yasuda, and T Sakurada, and M Yamamoto, and M Kikuchi, and M Okuyama, and K Miura
November 1970, Klinicheskaia meditsina,
Copied contents to your clipboard!